Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial

• Published in: The American heart journal 2015-04, Vol.169 (4), p.e7-e8
• Main Authors: Thiele, Holger, MD, Schuler, Gerhard, MD, Neumann, Franz-Josef, MD, Hausleiter, Jörg, MD, Olbrich, Hans-Georg, MD, Schwarz, Bettina, MD, Hennersdorf, Marcus, MD, Empen, Klaus, MD, Fuernau, Georg, MD, Desch, Steffen, MD, de Waha, Suzanne, MD, Eitel, Ingo, MD, Hambrecht, Rainer, MD, Böhm, Michael, MD, Kurowski, Volkhard, MD, Lauer, Bernward, MD, Minden, Hans-Heinrich, MD, Figulla, Hans-Reiner, MD, Braun-Dullaeus, Rüdiger C., MD, Strasser, Ruth H., MD, Rochor, Kristin, MD, Maier, Sebastian K.G., MD, Möllmann, Helge, MD, Schneider, Steffen, PhD, Ebelt, Henning, MD, Werdan, Karl, MD, Zeymer, Uwe, MD
• Format: Article
• Language: English
• Subjects: Cardiovascular; Heart attacks; Humans; Informed consent; Intra-Aortic Balloon Pumping; Myocardial Infarction - complications; Shock, Cardiogenic - therapy
• ISSN: 0002-8703; 1097-6744
• DOI: 10.1016/j.ahj.2015.01.009

The original text in the manuscript published in the American Heart Journal (2012;163:938-45) reads as follows:"Because most of the patients will not be able to provide full informed consent before randomization, an individualized informed consent process covering 4 different scenarios has been validated and approved by the central ethical committee at the University of Leipzig, Germany, and also all local ethical committees.